Merck Completes Acquisition of Themis
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St futures rise on tech buying, Middle East peace hopes
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil falls as traders digest escalation in US-Iran strikes
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- SAP stock dips after Oracle's massive AI spending plans
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
- UBS sees generational semiconductor boom, highlights stock winners
Mizuho Securities Reiterates Buy Rating on Merck (MRK)
June 23, 2020 6:55 AM EDTMizuho Securities analyst Mara Goldstein reiterated a Buy rating and $100.00 price target on Merck (NYSE: MRK) after KEYTRUDA is approved in China for 2L esophageal squamous cell carcinoma (ESCC) in PD-L1 positive tumors. This marks the fifth approved indication across three tumor... More
